$146 Million is the total value of First Light Asset Management, LLC's 62 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVS | NOVARTIS A Gadr | $571,000 | +3.8% | 6,070 | 0.0% | 0.39% | +5.4% | |
| ENDP | ENDO INTL PLCcs | $558,000 | -2.3% | 8,161 | 0.0% | 0.38% | -0.8% | |
| UTHR | UNITED THERAPEUTICS CORP DELcs | $491,000 | +45.3% | 3,820 | 0.0% | 0.34% | +47.4% | |
| V107SC | WELLPOINT INCcs | $490,000 | +11.1% | 4,095 | 0.0% | 0.34% | +12.8% | |
| HUM | HUMANA INCcs | $461,000 | +2.0% | 3,540 | 0.0% | 0.32% | +3.3% | |
| MYL | MYLAN LABS INCcs | $445,000 | -11.7% | 9,775 | 0.0% | 0.30% | -10.6% | |
| BMY | BRISTOL MYERS SQUIBB COcs | $424,000 | +5.5% | 8,290 | 0.0% | 0.29% | +7.0% | |
| AET | AETNA INC NEWcs | $422,000 | -0.2% | 5,215 | 0.0% | 0.29% | +1.4% | |
| AZN | ASTRAZENECA PLCadr | $406,000 | -3.8% | 5,680 | 0.0% | 0.28% | -2.1% | |
| CELG | CELGENE CORPcs | $406,000 | +10.3% | 4,280 | 0.0% | 0.28% | +12.1% | |
| JNJ | JOHNSON AND JOHNSONcs | $407,000 | +1.8% | 3,820 | 0.0% | 0.28% | +3.3% | |
| MRK | MERCK & CO INC NEWcs | $392,000 | +2.6% | 6,610 | 0.0% | 0.27% | +4.3% | |
| STJ | ST JUDE MED INCcs | $364,000 | -13.1% | 6,055 | 0.0% | 0.25% | -11.7% | |
| LLY | LILLY ELI AND COcs | $356,000 | +4.1% | 5,495 | 0.0% | 0.24% | +6.1% | |
| CFN | CAREFUSION CORPcs | $350,000 | +2.0% | 7,730 | 0.0% | 0.24% | +3.5% | |
| STE | STERIS CORPcs | $342,000 | +0.9% | 6,330 | 0.0% | 0.23% | +2.6% | |
| CYH | COMMUNITY HEALTH SYS INC NEWcs | $337,000 | +20.8% | 6,145 | 0.0% | 0.23% | +22.9% | |
| AMGN | AMGEN INCcs | $327,000 | +18.5% | 2,330 | 0.0% | 0.22% | +20.4% | |
| BDX | BECTON DICKINSON AND COcs | $318,000 | -3.9% | 2,795 | 0.0% | 0.22% | -2.2% | |
| PFE | PFIZER INCcs | $311,000 | -0.3% | 10,520 | 0.0% | 0.21% | +1.4% | |
| MYGN | MYRIAD GENETICS INCcs | $302,000 | -0.7% | 7,820 | 0.0% | 0.21% | +1.0% | |
| A | AGILENT TECHNOLOGIES INCcs | $292,000 | -0.7% | 5,120 | 0.0% | 0.20% | +1.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.